Cystic fibrosis (CF) remains a challenging condition for both patients and healthcare providers globally. This genetic disorder primarily affects the lungs and digestive system, causing persistent lung infections and progressive damage to the respiratory system. Despite these challenges, ongoing advancements in research and therapeutic developments are reshaping the landscape of CF treatment and care.